Sensititre MYCOTB MIC Plate for Testing Mycobacterium tuberculosis Susceptibility to First- and Second-Line Drugs
Jongseok Lee(International Tuberculosis Research Center), Moses Joloba(Makerere University), Clifton E. Barry(National Institutes of Health), Sandra Armakovitch(Boston University), Derek T. Armstrong(Johns Hopkins University), Willy Ssengooba(Makerere University), Carolyn Namaganda(Makerere University), Francis Mumbowa, David Alland(Rutgers, The State University of New Jersey), Yeuni Yu(International Tuberculosis Research Center), G. Chien(Boston University), Germine Nakayita(Makerere University), Jerrold J. Ellner(University Hospitals of Cleveland), Sang-Nae Cho(International Tuberculosis Research Center), Jeong-ae Park(International Tuberculosis Research Center), Laura E. Via(National Institutes of Health), Susan E. Dorman(Johns Hopkins University), Gerald Mboowa(Broad Institute)
Cited by 108
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548